Sundar Ramalingam

136O: Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial

Myung‐Ju Ahn, James Chih‐Hsin Yang, Helena A. Yu et al. · Journal of Thoracic Oncology · 2016 · 232 citations · Full text

Tumor Biology, Medicine, Pathology +8

Phase III study of maintenance gemcitabine (G) and best supportive care (BSC) versus BSC, following standard combination therapy with gemcitabine-carboplatin (G-Cb) for patients with advanced non-small cell lung cancer (NSCLC).

Chandra P. Belani, David Waterhouse, Hassan Ghazal et al. · Journal of Clinical Oncology · 2010 · 98 citations

Advanced Nsclc, Oncology, Cancer Management +10

SKYLINE2GPS: Localization in urban canyons using omni-skylines

Sundar Ramalingam, Slim Bouaziz, Peter Sturm et al. · 2010 · 78 citations

Engineering, Point Cloud Processing, New York +19

Enhancing the Surface Quality of Micro Titanium Alloy Specimen in WEDM Process by Adopting TGRA-Based Optimization

T. Muthuramalingam, A. C. Ramamurthy, Khaja Moiduddin et al. · Materials · 2020 · 69 citations · Full text

Engineering, Industrial Engineering, Mechanical Engineering +18

Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials

Sundar Ramalingam, Kenneth J. O’Byrne, Michael Boyer et al. · Annals of Oncology · 2016 · 56 citations · Full text